InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
2
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the detailed record of transactions filed by Garofalo Elizabeth A., Director. Director active across 3 companies, notably Acadia Pharmaceuticals INC. Cumulatively, 15 disclosures have been recorded. Split: 0 buy · 2 sells. Total volume traded: €120k. Activity tracked since 16 June 2022. The latest transaction was disclosed on 2 September 2025 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Garofalo Elizabeth A.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations15 total
28,700 sharesCommon StockSEC:0001193125-26-274132:0
8,107 sharesCommon StockSEC:0001826361-26-000002:0
1,600 shares@ US$25.975329.7% of flowCommon StockSEC:0001415889-25-023592:0
28,700 shares0Common StockSEC:0000950170-25-085618:0
9,387 sharesCommon StockSEC:0001415889-25-015272:0
4,919 shares@ US$18.23100.0% of flowCommon StockSEC:0001415889-25-007299:0
35,000 shares0Common StockSEC:0000950170-24-072516:0
6,652 sharesCommon StockSEC:0001415889-24-015088:0
3,500 shares@ US$18.56100.0% of flowCommon SharesSEC:0000950170-24-029542:0
9,459 shares0Common StockSEC:0000950170-23-068620:0
2,918 shares0Common StockSEC:0001209191-23-056827:0
26,250 shares0Common StockSEC:0000950170-23-028267:0
6,391 sharesCommon StockSEC:0001209191-23-034694:0
9,459 shares0Common StockSEC:0001209191-22-038536:0
1,918 sharesCommon StockSEC:0001209191-21-058556:0
15 of 15 declarations
About Garofalo Elizabeth A.
GAROFALO ELIZABETH A. is Administrateur and has 15 filings in total. Across the 15 filings observed between 2021-10-01 and 2026-06-17, sales total 120100 EUR and the most common transaction nature is Levée d'options. The filings concern Acadia Pharmaceuticals INC, Alector, Inc. and Xenon Pharmaceuticals Inc., including sales at Acadia Pharmaceuticals INC on 2025-03-06 and 2025-09-03.
